A tractable microscopy- and flow cytometry-based method to measure natural killer cell-mediated killing and infiltration of tumor spheroids

Balsamo, 2013, Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC, European Journal of Immunology, 43, 2756, 10.1002/eji.201343448 Barry, 2018, A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments, Nature Medicine, 24, 1178, 10.1038/s41591-018-0085-8 Bell, 2001, The development of necrosis and apoptosis in glioma: Experimental findings using spheroid culture systems, Neuropathology and Applied Neurobiology, 27, 291, 10.1046/j.0305-1846.2001.00319.x Bergdorf, 2021, Immunofluorescent staining of cancer spheroids and fine-needle aspiration-derived organoids, STAR Protocols, 2, 10.1016/j.xpro.2021.100578 Böttcher, 2018, NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control, Cell, 172, 1022, 10.1016/j.cell.2018.01.004 Boucherit, 2020, 3D tumor models and their use for the testing of immunotherapies, Frontiers in Immunology, 11, 10.3389/fimmu.2020.603640 Carlsten, 2009, Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells, Journal of Immunology, 183, 4921, 10.4049/jimmunol.0901226 Cerwenka, 2001, Natural killer cells, viruses and cancer, Nature Reviews. Immunology, 1, 41, 10.1038/35095564 Chen, 2021, Phosphodiesterase 4A confers resistance to PGE2-mediated suppression in CD25+/CD54+ NK cells, EMBO Reports, 22, 10.15252/embr.202051329 Cichocki, 2020, iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy, Science Translational Medicine, 12, 10.1126/scitranslmed.aaz5618 Concha-Benavente, 2018, PD-L1 mediates dysfunction in activated PD-1(+) NK cells in head and neck cancer patients, Cancer Immunology Research, 6, 1548, 10.1158/2326-6066.CIR-18-0062 Cong, 2018, Dysfunction of natural killer cells by FBP1-induced inhibition of glycolysis during lung cancer progression, Cell Metabolism, 28, 243, 10.1016/j.cmet.2018.06.021 Cossarizza, 2017, Guidelines for the use of flow cytometry and cell sorting in immunological studies, European Journal of Immunology, 47, 1584, 10.1002/eji.201646632 Cossarizza, 2019, Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition), European Journal of Immunology, 49, 1457, 10.1002/eji.201970107 Coudert, 2005, Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells, Blood, 106, 1711, 10.1182/blood-2005-03-0918 Gajewski, 2013, Innate and adaptive immune cells in the tumor microenvironment, Nature Immunology, 14, 1014, 10.1038/ni.2703 Gheytanchi, 2021, Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines, Cancer Cell International, 21, 204, 10.1186/s12935-021-01898-9 Gottfried, 2016, Tumor-derived lactic acid modulates dendritic cell activation and antigen expression, Immunobiology, 107, 2013 Groebe, 1991, Distributions of oxygen, nutrient, and metabolic waste concentrations in multicellular spheroids and their dependence on spheroid parameters, European Biophysics Journal, 19, 169, 10.1007/BF00196343 Ishigami, 2000, Prognostic value of intratumoral natural killer cells in gastric carcinoma, Cancer, 88, 577, 10.1002/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V Liu, 2017, Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers, Oncogene, 36, 6143, 10.1038/onc.2017.209 Liu, 2020, Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors, The New England Journal of Medicine, 382, 545, 10.1056/NEJMoa1910607 Luna, 2017, Targeting cancer stem cells with natural killer cell immunotherapy, Expert Opinion on Biological Therapy, 17, 313, 10.1080/14712598.2017.1271874 Mamessier, 2011, Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity, The Journal of Clinical Investigation, 121, 3609, 10.1172/JCI45816 Maude, 2018, Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia, The New England Journal of Medicine, 378, 439, 10.1056/NEJMoa1709866 Mori, 2019, ALDH-dependent glycolytic activation mediates stemness and paclitaxel resistance in patient-derived spheroid models of uterine endometrial cancer, Stem Cell Reports, 13, 730, 10.1016/j.stemcr.2019.08.015 Nascimento Silva, 2022, Process development for adoptive cell therapy in academia: A pipeline for clinical-scale manufacturing of multiple TCR T cell products, Frontiers in Immunology Neelapu, 2017, Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma, The New England Journal of Medicine, 377, 2531, 10.1056/NEJMoa1707447 Neo, 2020, CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment, The Journal of Clinical Investigation, 130, 1185, 10.1172/JCI128895 Nersesian, 2021, NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis, Translational Oncology, 14, 10.1016/j.tranon.2020.100930 Ni, 2020, Single-cell RNA sequencing of tumor-infiltrating NK cells reveals that inhibition of transcription factor HIF-1a unleashes NK cell activity, Immunity, 52, 1075, 10.1016/j.immuni.2020.05.001 Oh, 2019, Natural killer cell therapy: A new treatment paradigm for solid tumors, Cancers (Basel), 11, E1534, 10.3390/cancers11101534 Palucka, 2016, The basis of oncoimmunology, Cell, 164, 1233, 10.1016/j.cell.2016.01.049 Parodi, 2018, Hypoxia modifies the transcriptome of human NK cells, modulates their immunoregulatory profile, and influences NK cell subset migration, Frontiers in Immunology, 9, 2358, 10.3389/fimmu.2018.02358 Peng, 2013, Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer, gastric cancer, and colorectal cancer, Journal of Translational Medicine, 11, 262, 10.1186/1479-5876-11-262 Phillips, 1986, Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis, The Journal of Experimental Medicine, 164, 814, 10.1084/jem.164.3.814 Platonova, 2011, Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma, Cancer Research, 71, 5412, 10.1158/0008-5472.CAN-10-4179 Rosenberg, 1987, A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone, The New England Journal of Medicine, 316, 889, 10.1056/NEJM198704093161501 Schuster, 2019, Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma, The New England Journal of Medicine, 380, 45, 10.1056/NEJMoa1804980 Sun, 2017, High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer, Oncoimmunology, 6, 10.1080/2162402X.2016.1264562 Sun, 2019, Human CD96 correlates to natural killer cell exhaustion and predicts the prognosis of human hepatocellular carcinoma, Hepatology, 70, 168, 10.1002/hep.30347 Sutherland, 1988, Cell and environment interactions in tumor microregions: The multicell spheroid model, Science, 240, 177, 10.1126/science.2451290 Tallerico, 2017, NK cells control breast cancer and related cancer stem cell hematological spread, Oncoimmunology, 6, 10.1080/2162402X.2017.1284718 Vitale, 2022, Tumor microenvironment and hydrogel-based 3D cancer models for in vitro testing immunotherapies, Cancers (Basel), 14, 1013, 10.3390/cancers14041013 Yang, 2020, Thioredoxin activity confers resistance against oxidative stress in tumor-infiltrating NK cells, The Journal of Clinical Investigation, 130, 5508, 10.1172/JCI137585 Zhang, 2020, Prognostic significance of tumor-infiltrating natural killer cells in solid tumors: A systematic review and meta-analysis, Frontiers in Immunology, 11, 1242, 10.3389/fimmu.2020.01242